3D Signatures
develops diagnostic and prognostic products to provide personalized medicine for the treatment of cancer and alzheimers disease... Read more3D Signatures
develops diagnostic and prognostic products to provide personalized medicine for the treatment of cancer and alzheimers disease... Read more
News
Apr 08, 2019
GlobeNewswire
Press Release: 3D Signatures : 3D Signatures Announces Name Change to Telo Genomics Corp.
Mar 15, 2019
4-traders
3D Signatures: 3D Signatures : Report of Voting Results
Nov 09, 2018
BioPortfolio
3D Signatures: 3D Signatures Inc DXD Medical Equipment Deals and Alliances Profile Report Updated 23102018 Prices from USD $250
Sep 02, 2018
BioPortfolio
3D Signatures: 3D Signatures Inc DXD Product Pipeline Analysis 2018 Update Report Updated 09052018 Prices from USD $750
May 31, 2018
Silver Investing News
3D Signatures: 3D Signatures Announces Intention to File for Bankruptcy
May 10, 2018
PharmiWeb
3D Signatures: 3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer's Disease, Hodgkin's Lymphoma and Multiple Myeloma
Apr 03, 2018
BioPortfolio
3D Signatures: 3D Signatures Inc. Announces Successful Scoring Model Development and Analytical Validation of the TeloHLTM Test for Hodgkin's Lymphoma
Mar 28, 2018
360DX
3D Signatures: 3D Signatures, MDxHealth to Evaluate Prostate Cancer Test
Mar 06, 2018
Silver Investing News
3D Signatures: 3D Signatures and l'Institut Universitaire de Cardiologie et de Pneumologie de Québec Announce Collaboration
Mar 06, 2018
ECONOTIMES
Press Release: 3D Signatures : 3D Signatures Inc. and l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Announce Collaboration to Combine TeloView with Genome Sequence Analysis in Lung Cancer
3D Signatures Competitors
1
2
3
4
5
6
7
8
9